Medical Instruments & Supplies · Toowong, QLD 4066, Australia
$9.71
-0.92% (-$0.09)2026-07-08
Smart-Money SignalNeutral · 45/100— Insiders are net buyers over 90 days ($102K, 4 buys vs 4 sales)
Revenue$494.0K
Net Income-$23.0M
EPS$-0.28
Market Cap$944.1M
Price Performance
Historical data including institutional events
Company Profile
W
Wayne Paterson
CEO & Executive Director
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta.
Anteris Technologies Global Corp. is based in Toowong, Australia.
